Breast Cancer
Reports from Erasmus University highlight recent research in breast cancer
Published in Women's Health Weekly, August 27th, 2009
According to recent research from Rotterdam, Netherlands, "In 2005 the Dutch national guidelines for treatment of breast cancer were updated. From then onwards, patients with operable breast cancer, who formerly received four cycles of adjuvant chemotherapy with doxorubicin/cyclophosphamide (AC), were treated with five cycles Of 5-fluorouracil/epirubicin/cyclophosphamide (FEC), based on data suggesting survival benefit."
"Primary objective: evaluation of the effect on quality-of-life and trainability after four AC versus five FEC cycles of polychemotherapy. Secondary objective: evaluation of the effectiveness of an 18-week training programme for breast cancer survivors....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- American Cancer Society
Young early stage ovarian cancer patients can preserve fertility - JAMA and Archives Journals
Aspirin use after colorectal cancer diagnosis associated with improved survival - Journal of the National Cancer Institute
The public overestimates benefits of cancer screening, survey finds - Massachusetts General Hospital
Denosumab increases bone density, cuts fracture risk in prostate cancer survivors - SAGE Publications
How to make negative services less unpleasant for consumers - University of Illinois at Chicago
Botanicals have no effect on hot flashes or cognition: Study - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
